Approov Runtime Application Self Protection vs ImmuniWeb® MobileSuite: Side-by-Side Comparison (2026)

Approov Runtime Application Self Protection: RASP solution securing mobile apps and APIs across Android, iOS, and HarmonyOS at runtime. built by Approov. Core capabilities include App attestation to verify app authenticity and device integrity at runtime, Real-time threat intelligence on deployed apps and their operating environments, Dynamic certificate pinning with over-the-air updates to block MitM attacks..

ImmuniWeb® MobileSuite: ImmuniWeb MobileSuite is a mobile application penetration testing platform that combines AI-powered automation with manual security testing to assess mobile apps and their backend infrastructure for security vulnerabilities and compliance requirements. built by ImmuniWeb. Core capabilities include Mobile Application Penetration Testing, Zero False-Positives SLA, Rapid Delivery SLA..

Both serve the Mobile App Security market but differ in approach, feature depth, and target audience.

Approov Runtime Application Self Protection differentiates with App attestation to verify app authenticity and device integrity at runtime, Real-time threat intelligence on deployed apps and their operating environments, Dynamic certificate pinning with over-the-air updates to block MitM attacks. ImmuniWeb® MobileSuite differentiates with Mobile Application Penetration Testing, Zero False-Positives SLA, Rapid Delivery SLA.

Approov Runtime Application Self Protection is developed by Approov. ImmuniWeb® MobileSuite is developed by ImmuniWeb. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

Approov Runtime Application Self Protection and ImmuniWeb® MobileSuite serve similar Mobile App Security use cases: both are Mobile App Security tools. Review the feature comparison above to determine which fits your requirements.